THE PHARMACOKINETICS OF FLUCONAZOLE DURING HEMODIALYSIS IN UREMIC PATIENTS

被引:0
作者
OONO, S [1 ]
TABEI, K [1 ]
TETSUKA, T [1 ]
ASANO, Y [1 ]
机构
[1] JICHI MED SCH,DEPT MED,DIV NEPHROL,3311-1 MINAMIKAWACHI MACHI,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
关键词
FLUCONAZOLE; HEMODIALYSIS; FUNGAL INFECTION; UREMIA PHARMACOKINETICS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have studied the pharmacokinetics of fluconazole in five patients on long-term haemodialysis. The single-pass extraction rate of the dialyzer was 59 (3.5)% (n = 4), and the serum concentration was reduced by haemodialysis for 3 or 4 h by 26 (3.2)% (n = 5) and 39 (2.2)% (n = 9) respectively. The estimated amount extracted by a dialysis of 4 h was 33 (3.2)% (n = 4) of the dose. During repeated administration the serum fluconazole concentration increased, reaching a plateau at about 4 times the peak concentration after the first dose. After discontinuing administration the serum fluconazole concentration fell by 25% in every 3 h dialysis session. We conclude that fluconazole should be given in the usual dose of 100 or 200 mg at the end of every haemodialysis session.
引用
收藏
页码:667 / 670
页数:4
相关论文
共 50 条
  • [11] Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients
    Aoyama, T.
    Hirata, K.
    Hirata, R.
    Yamazaki, H.
    Yamamoto, Y.
    Hayashi, H.
    Matsumoto, Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (03) : 356 - 363
  • [12] Prevalence of uremic itching in patients undergoing hemodialysis
    Kavurmaci, Mehtap
    HEMODIALYSIS INTERNATIONAL, 2015, 19 (04) : 531 - 535
  • [13] Gastric dysrhythmia in uremic patients on maintenance hemodialysis
    Ko, CW
    Chang, CS
    Lien, HC
    Wu, MJ
    Chen, GH
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (10) : 1047 - 1051
  • [14] Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients
    Diana Moldovan
    Crina Rusu
    Alina Potra
    Ioan Moldovan
    Ioan Mihai Patiu
    Mirela Gherman-Caprioara
    Ina Maria Kacso
    International Urology and Nephrology, 2017, 49 : 895 - 901
  • [15] Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients
    Moldovan, Diana
    Rusu, Crina
    Potra, Alina
    Moldovan, Ioan
    Patiu, Ioan Mihai
    Gherman-Caprioara, Mirela
    Kacso, Ina Maria
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (05) : 895 - 901
  • [16] Survival of hemodialysis patients and uremic toxin removal
    Vanholder, R
    De Smet, R
    Glorieux, G
    Dhondt, A
    ARTIFICIAL ORGANS, 2003, 27 (03) : 218 - 223
  • [17] THE COURSE OF AUTONOMIC NEURAL FUNCTION IN CHRONIC UREMIC PATIENTS DURING HEMODIALYSIS-TREATMENT
    VITA, G
    SAVICA, V
    PUGLISI, RM
    MARABELLO, L
    BELLINGHIERI, G
    MESSINA, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (10) : 1022 - 1025
  • [18] FOLLOW-UP OF NERVE-CONDUCTION IN CHRONIC UREMIC PATIENTS DURING HEMODIALYSIS
    LEONE, M
    BOTTACCHI, E
    ALLOATTI, S
    NEBIOLO, PE
    AIMINO, M
    BALDINI, S
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1992, 13 (04): : 317 - 321
  • [19] Special pharmacokinetics of fluconazole in septic, obese and burn patients
    Pittrow, L
    Penk, A
    MYCOSES, 1999, 42 : 87 - 90
  • [20] Modulation of neutrophil apoptosis by uremic plasma during hemodialysis
    Jaber, BL
    Balakrishnan, VS
    Cendoroglo, MN
    Perianayagan, MC
    King, AJ
    Pereira, BJG
    BLOOD PURIFICATION, 1998, 16 (06) : 325 - 335